| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.9 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.9 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |